Opus Genetics, Inc.

Opus Genetics (IRD) has logged zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in our near-term monitoring window. However, low signal in a 90-day snapshot does not eliminate underlying risks; historical patterns, equity dilution exposure, and financing dependency require deeper analysis. The full $49 Report extends the timeline to 12 months, calculates dilution risk scores, maps the complete 8-K filing context, and surfaces AI-detected financing pressure signals that shape long-term shareholder value. The full $49 Report adds dilution trajectory modeling, 12-month red-flag history, and financing sustainability scoring.